Conversely, increased MBOAT7 expression is correlated with detrimental outcomes in cancers, such as hepatocellular carcinoma and clear cell renal carcinomas29,30, suggesting that inhibitors of MBOAT7 may be useful therapeutic agents. The gene discussed is MBOAT7; the disease is cancer.